Literature DB >> 7800957

Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease.

M Sofia1, M Mormile, S Faraone, P Carratù, M Alifano, G Di Benedetto, L Carratù.   

Abstract

Abnormalities in endothelin-1 (ET-1) pulmonary metabolism have been reported in patients with pulmonary hypertension, asthma and chronic obstructive pulmonary disease (COPD). In this study we have evaluated the 24-hour urinary excretion of ET-1 in COPD patients both during acute exacerbation and stable phase of the disease. ET-1 plasma and urinary levels were measured in 13 COPD patients on admission to the hospital for an acute exacerbation and at the recovery period. Ten healthy volunteers were also studied. Determination of plasma and 24-Hour urinary ET-1 levels were carried out with a radioimmunoassay test. Plasma ET-1 levels in COPD patients were similar during exacerbation and recovery and were not significantly different from those in the healthy subjects. 24-hour urinary excretion of ET-1 was increased in COPD patients during acute exacerbation; it decreased during recovery, but remained elevated when compared to normal subjects. A negative correlation was found between arterial oxygen pressure and ET-1 excretion; no correlation was found between plasma and urinary ET-1 values. In conclusion, COPD patients excrete higher amounts of ET-1 compared to healthy subjects. Urinary ET-1 values are further increased during acute exacerbation of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7800957     DOI: 10.1159/000196349

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  5 in total

Review 1.  New therapies for chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

2.  Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.

Authors:  M Roland; A Bhowmik; R J Sapsford; T A Seemungal; D J Jeffries; T D Warner; J A Wedzicha
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

Review 3.  Role of endothelin-1 in lung disease.

Authors:  K A Fagan; I F McMurtry; D M Rodman
Journal:  Respir Res       Date:  2001-02-22

4.  Choroid and Retinal Nerve Fiber Layer Thickness in Patients with Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Özkan Kocamış; Duygu Zorlu
Journal:  J Ophthalmol       Date:  2018-07-08       Impact factor: 1.909

5.  Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension.

Authors:  Pierluigi Carratu; Cristina Scoditti; Mauro Maniscalco; Teresa Maria Seccia; Giuseppe Di Gioia; Felice Gadaleta; Rosa Angela Cardone; Silvano Dragonieri; Paola Pierucci; Antonio Spanevello; Onofrio Resta
Journal:  BMC Pulm Med       Date:  2008-09-26       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.